You are here: Industry Insights > Market News > Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

firstwordpharmaJuly 12, 2021

Tag: Sputnik V , COVID-19 , mRNA vaccine , SARS-CoV-2

Favorites

Viral vector and mRNA vaccines, including Russia's Sputnik V, provide enough protection against the new Delta strain of the coronavirus, albeit to a lesser extent, reported The Times of India.

The observation was made by Sergey Netesov, head of the Novosibirsk State University's Laboratory and member of the Russian Academy of Sciences.

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

They offered 95% protection against the initial strain and now they give 90% protection against the Delta variant, Netesov said.

Sputnik V uses two different engineered adenoviruses (rAd26 and rAd5 for the first and second doses, respectively) to deliver the genetic code for the spike protein of SARS-CoV-2.

Previous:Unvaccinated Belgian woman contracted two COVID variants simultaneously

Next:Israeli co Bonus BioGroup reports Covid-19 treatment success

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may like
More>>

Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may likeMore>>

You may like
More>>